Page last updated: 2024-11-05

1-(2-pyridylazo)-2-naphthol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1-(2-pyridylazo)-2-naphthol, also known as PAN, is a chelating agent used in analytical chemistry for the spectrophotometric determination of various metal ions, including copper, zinc, cobalt, nickel, and iron. It forms colored complexes with these metals, enabling their quantification based on the intensity of the color produced. PAN is synthesized by reacting 2-aminopyridine with 2-naphthol in the presence of a suitable oxidizing agent. Its ability to form stable and colored complexes with metal ions makes it a valuable reagent for various analytical techniques, such as titrations, spectrophotometry, and chromatography. The formation of these complexes is influenced by factors such as pH, temperature, and the presence of other ligands. Research on PAN focuses on its applications in metal analysis, environmental monitoring, and the development of new analytical methods.'

Cross-References

ID SourceID
PubMed CID6825
CHEMBL ID1400298
CHEBI ID194272
SCHEMBL ID272188
SCHEMBL ID4947540
SCHEMBL ID11882717
SCHEMBL ID11882710
MeSH IDM0123619

Synonyms (64)

Synonym
pan (van)
2-naphthol, 1-(2-pyridylazo)-
pan (indicator)
85-85-8
2-naphthalenol, 1-(2-pyridinylazo)-
2-hydroxy-1-(2-pyridylazo)naphthalene
1-(2-pyridylazo)-2-hydroxynaphthalene
nsc5332
nsc-5332
1-(2-pyridylazo)-2-naphthol ,
1-(pyridin-2-yldiazenyl)-2-naphthol
AN-652/40913915
MLS000540127 ,
smr000162402
1-(2-pyridylazo)-2-naphthol, indicator grade
SR-01000638946-1
raxumgmwxzyadr-sdxdjhtjsa-
inchi=1/c15h11n3o/c19-13-9-8-11-5-1-2-6-12(11)15(13)18-17-14-7-3-4-10-16-14/h1-10h,(h,16,17)/b18-15-
(1z)-1-(pyridin-2-ylhydrazinylidene)naphthalen-2-one
1-(2-pyridin-2-yldiazenyl)-2-naphthol
1-(pyridin-2-yldiazenyl)naphthalen-2-ol
CHEBI:194272
(1e)-1-(2-pyridylhydrazono)naphthalen-2-one
A841465
AKOS004901457
NCGC00247231-01
HMS2310J23
CCG-49495
unii-095b53y3xv
einecs 201-637-9
1-(pyridin-2-azo)-2-naphthol
2-naphthalenol, 1-(2-(2-pyridinyl)diazenyl)-
095b53y3xv ,
nsc 5332
pan [mi]
pyridine, 2-(2-hydroxy-1-naphthylazo)-
1-(2-pyridylazo)naphthol-2
2-hydroxy-1-(pyridin-2-yldiazenyl)naphthalene
1-(2'-pyridylazo)-2-naphthol
SCHEMBL272188
SCHEMBL4947540
SCHEMBL11882717
SCHEMBL11882710
DTXSID5058933
W-104075
1-[(e)-2-pyridinyldiazenyl]-2-naphthol #
LLYOXZQVOKALCD-ISLYRVAYSA-N
(1z)-1-(2-pyridinylhydrazinylidene)-2-naphthalenone
(1z)-1-(2-pyridylhydrazono)naphthalen-2-one
cid_5359275
bdbm48080
CHEMBL1400298
mfcd00004071
1-[(e)-pyridin-2-yldiazenyl]naphthalen-2-ol
STL453606
AKOS028109811
1-(2-pyridylazo)-2-naphthol, for spectrophotometric det. of metal ions, >=97.0%
AS-59143
1-[(1e)-2-(pyridin-2-yl)diazen-1-yl]naphthalen-2-ol
CS-0010135
Q3596751
(e)-1-(pyridin-2-yldiazenyl)naphthalen-2-ol
D88559
1.2-pyridylazo-2-naphthol

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"A straightforward and efficient method was developed by ultrasound assisted emulsification microextraction (USAEME) combined with inductively coupled plasma optical emission spectroscopy (ICP/OES) to trace some toxic heavy metal ions in eight select farmed and four select imported rice samples."( Determination of toxic heavy metals in rice samples using ultrasound assisted emulsification microextraction combined with inductively coupled plasma optical emission spectroscopy.
Bozorgzadeh, E; Ebrahimi-Najafabadi, H; Pasdaran, A; Rezaei Bezenjani, R, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (51)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency1.25890.004023.8416100.0000AID485290
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency35.48130.631035.7641100.0000AID504339
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency35.48130.177814.390939.8107AID2147
Chain A, Ferritin light chainEquus caballus (horse)Potency14.12545.623417.292931.6228AID485281
LuciferasePhotinus pyralis (common eastern firefly)Potency15.10140.007215.758889.3584AID588342
Nrf2Homo sapiens (human)Potency4.93990.09208.222223.1093AID624171; AID651593; AID651597
glp-1 receptor, partialHomo sapiens (human)Potency18.62980.01846.806014.1254AID624172; AID624417
BRCA1Homo sapiens (human)Potency1.99530.89137.722525.1189AID624202
ATAD5 protein, partialHomo sapiens (human)Potency0.73080.004110.890331.5287AID504467
TDP1 proteinHomo sapiens (human)Potency0.61590.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency5.01190.180013.557439.8107AID1460
apical membrane antigen 1, AMA1Plasmodium falciparum 3D7Potency10.00000.707912.194339.8107AID720542
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency10.00000.011212.4002100.0000AID1030
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency0.28180.28189.721235.4813AID2326
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency3.98110.707936.904389.1251AID504333
IDH1Homo sapiens (human)Potency5.17350.005210.865235.4813AID686970
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency3.16230.035520.977089.1251AID504332
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency1.25890.01262.451825.0177AID485313
polyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)Potency11.22021.000012.232631.6228AID1452
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency31.62280.001815.663839.8107AID894
chromobox protein homolog 1Homo sapiens (human)Potency8.91250.006026.168889.1251AID540317
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency29.09290.00419.984825.9290AID504444
huntingtin isoform 2Homo sapiens (human)Potency3.16230.000618.41981,122.0200AID1688
DNA polymerase betaHomo sapiens (human)Potency35.48130.022421.010289.1251AID485314
flap endonuclease 1Homo sapiens (human)Potency44.66840.133725.412989.1251AID588795
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency75.68630.425612.059128.1838AID504891
DNA polymerase eta isoform 1Homo sapiens (human)Potency28.18380.100028.9256213.3130AID588591
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency1.72210.00798.23321,122.0200AID2546; AID2551
lethal(3)malignant brain tumor-like protein 1 isoform IHomo sapiens (human)Potency10.00000.075215.225339.8107AID485360
gemininHomo sapiens (human)Potency3.16110.004611.374133.4983AID624296; AID624297
VprHuman immunodeficiency virus 1Potency35.48131.584919.626463.0957AID651644
survival motor neuron protein isoform dHomo sapiens (human)Potency3.16230.125912.234435.4813AID1458
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency11.22020.00419.962528.1838AID2675
lamin isoform A-delta10Homo sapiens (human)Potency17.78280.891312.067628.1838AID1487
neuropeptide S receptor isoform AHomo sapiens (human)Potency7.94330.015812.3113615.5000AID1461
Glycoprotein hormones alpha chainHomo sapiens (human)Potency3.98114.46688.344810.0000AID624291
Guanine nucleotide-binding protein GHomo sapiens (human)Potency28.18381.995325.532750.1187AID624287
Inositol monophosphatase 1Rattus norvegicus (Norway rat)Potency8.91251.000010.475628.1838AID1457
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nonstructural protein 1Influenza A virus (A/California/07/2009(H1N1))IC50 (µMol)13.85500.200024.4540100.0000AID504329
kappa-type opioid receptor isoform 1Homo sapiens (human)IC50 (µMol)18.56000.00322.673715.6000AID1778; AID2136
exodeoxyribonuclease V subunit RecBEscherichia coli str. K-12 substr. MG1655IC50 (µMol)118.47300.10000.10000.1000AID492957
exodeoxyribonuclease V subunit RecCEscherichia coli str. K-12 substr. MG1655IC50 (µMol)118.47300.10000.10000.1000AID492957
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Hsf1 proteinMus musculus (house mouse)EC50 (µMol)11.37100.160024.4900236.5000AID2382
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)EC50 (µMol)25.70000.00132.612925.7000AID1966
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)EC50 (µMol)25.70000.00133.394625.7000AID1966
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)EC50 (µMol)25.70000.00133.394625.7000AID1966
Beta-galactosidaseEscherichia coliEC50 (µMol)25.700025.700025.700025.7000AID1966
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LMP1 [Human herpesvirus 4]human gammaherpesvirus 4 (Epstein-Barr virus)AC503.98350.068039.9389277.4300AID504861; AID504882
heat shock protein HSP 90-alpha isoform 2Homo sapiens (human)AC502.69900.19503.667918.6960AID540270
heat shock protein 90, putativePlasmodium falciparum 3D7AC502.66200.19504.992098.5000AID540268
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (18)

Processvia Protein(s)Taxonomy
G protein-coupled receptor signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of cell population proliferationGlycoprotein hormones alpha chainHomo sapiens (human)
hormone-mediated signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
regulation of signaling receptor activityGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of steroid biosynthetic processGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of cell migrationGlycoprotein hormones alpha chainHomo sapiens (human)
thyroid gland developmentGlycoprotein hormones alpha chainHomo sapiens (human)
luteinizing hormone secretionGlycoprotein hormones alpha chainHomo sapiens (human)
organ growthGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIGlycoprotein hormones alpha chainHomo sapiens (human)
negative regulation of organ growthGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone secretionGlycoprotein hormones alpha chainHomo sapiens (human)
thyroid hormone generationGlycoprotein hormones alpha chainHomo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
hormone activityGlycoprotein hormones alpha chainHomo sapiens (human)
protein bindingGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone activityGlycoprotein hormones alpha chainHomo sapiens (human)
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
extracellular regionGlycoprotein hormones alpha chainHomo sapiens (human)
extracellular spaceGlycoprotein hormones alpha chainHomo sapiens (human)
Golgi lumenGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone complexGlycoprotein hormones alpha chainHomo sapiens (human)
pituitary gonadotropin complexGlycoprotein hormones alpha chainHomo sapiens (human)
extracellular spaceGlycoprotein hormones alpha chainHomo sapiens (human)
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (56)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (7.14)18.7374
1990's1 (1.79)18.2507
2000's14 (25.00)29.6817
2010's33 (58.93)24.3611
2020's4 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.19 (24.57)
Research Supply Index4.13 (2.92)
Research Growth Index5.40 (4.65)
Search Engine Demand Index41.66 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.64%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other60 (98.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]